CINECA IRIS Institutional Research Information System

MONTRUCCHIO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.844
EU - Europa 3.375
AS - Asia 1.134
SA - Sud America 26
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 8.417
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.773
CN - Cina 813
IT - Italia 667
DK - Danimarca 437
IE - Irlanda 431
SE - Svezia 344
UA - Ucraina 317
DE - Germania 281
FR - Francia 266
FI - Finlandia 203
KR - Corea 173
GB - Regno Unito 133
PL - Polonia 92
AT - Austria 68
VN - Vietnam 60
CA - Canada 58
BE - Belgio 45
RU - Federazione Russa 18
PT - Portogallo 16
JP - Giappone 15
ES - Italia 14
IN - India 14
SN - Senegal 14
CH - Svizzera 13
TH - Thailandia 11
CO - Colombia 10
NL - Olanda 10
PH - Filippine 10
BR - Brasile 8
AU - Australia 7
MX - Messico 7
RO - Romania 6
EU - Europa 5
HK - Hong Kong 5
TW - Taiwan 5
UZ - Uzbekistan 5
HT - Haiti 4
ID - Indonesia 4
SA - Arabia Saudita 4
TR - Turchia 4
A1 - Anonimo 3
NG - Nigeria 3
UY - Uruguay 3
AR - Argentina 2
BG - Bulgaria 2
BY - Bielorussia 2
DM - Dominica 2
HR - Croazia 2
IL - Israele 2
LU - Lussemburgo 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
SG - Singapore 2
BD - Bangladesh 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KZ - Kazakistan 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 8.417
Salva come PNG Salva come JPEG
Città #
Ann Arbor 675
Beijing 613
Chandler 533
Dublin 428
Jacksonville 233
Villeurbanne 183
Torino 182
Dearborn 178
Wilmington 150
Princeton 141
Houston 135
Fairfield 134
Medford 118
Nyköping 117
Warsaw 92
Ashburn 81
Woodbridge 70
Vienna 66
Milan 59
Boston 55
Seattle 52
Dong Ket 44
Fremont 44
Cambridge 43
Brussels 42
Pisa 37
Hefei 31
Boardman 30
Redwood City 27
Guangzhou 26
Munich 25
San Mateo 24
Toronto 24
Turin 23
Verona 23
Washington 23
Nanjing 15
Shanghai 15
Norwalk 14
Falls Church 13
Chicago 12
Detroit 12
Kunming 12
Buffalo 11
Montréal 10
Palaiseau 10
San Diego 10
Grafing 9
Nanchang 9
Hangzhou 8
Lachine 8
Alessandria 7
Florence 7
Mountain View 7
Ottawa 7
Perugia 7
Trieste 7
Jinan 6
Rome 6
Upper Marlboro 6
Xian 6
Zhengzhou 6
Bologna 5
Chengdu 5
Düsseldorf 5
Hebei 5
Modena 5
Palermo 5
Pavia 5
Shenyang 5
Taipei 5
Teresina 5
Tokyo 5
Auburn Hills 4
Baotou 4
Bari 4
Boydton 4
Central District 4
Fuzhou 4
London 4
Madrid 4
New York 4
Nürnberg 4
Padova 4
Phoenix 4
Port-au-Prince 4
Saint Petersburg 4
Santa Flavia 4
Silver Spring 4
Wuhan 4
Bengaluru 3
Catania 3
Chongqing 3
Edinburgh 3
Ferrara 3
Lausanne 3
Mexico City 3
Middletown 3
Montevideo 3
Palazzolo sull'Oglio 3
Totale 5.154
Salva come PNG Salva come JPEG
Nome #
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 386
Joint use of cardio-embolic and bleeding risk scorers in elderly patients with atrial fibrillation. 288
Bleeding prevalence and transfusion requirement in patients with thrombocytopenia in the emergency department 271
Phosphoinositide 3-kinase gamma controls autonomic regulation of the mouse heart through Gi-independent downregulation of cAMP level 225
Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility. 216
Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing 212
Ablation of phosphoinositide 3-kinase-gamma reduces the severity of acute pancreatitis 211
Resistance to thromboembolism in PI3-K gamma-deficient mice 201
THE STORM (acute coronary Syndrome in paTients end Of life and Risk assesMent) study Claudio Moretti 201
Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease 186
Role of phosphoinositide 3-kinase in the pathogenesis of acute pancreatitis. 169
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 166
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 163
Increased levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria 149
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 139
Pancreatic-carcinoma-cell-derived pro-angiogenic factors can induce endothelial-cell differentiation of a subset of circulating CD34+ progenitors. 125
Blockade of thrombopoietin reduces organ damage in experimental endotoxemia and polymicrobial sepsis 118
Effect of cytokines on the cytoskeleton of resident glomerular cells. 115
AISF position paper on HCV in immunocompromised patients 115
Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: Expression and prognostic significance 107
[Physiopathological mechanisms in the natural history of the atherosclerotic plaque] 103
Platelets and multi-organ failure in sepsis 101
Elevated thrombopoietin in plasma of burned patientswithout and with sepsis enhances platelet activation 100
May thrombopoietin be a useful marker of sepsis severity assessment in patients with SIRS entering the emergency department? 98
Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes 94
Thrombopoietin as early biomarker of disease severity in patients with acute pancreatitis 92
Thrombopoietin modulates cardiac contractility in vitro and contributes to myocardial depressing activity of septic shock serum 92
Thrombopoietin contributes to enhanced platelet activation in cigarette smokers 87
Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. 84
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. 83
Effect of platelet activating factor on guinea pig papillary muscle. 77
Cooperative role of thrombopoietin and vascular endothelial growth factor-a in the progression of liver cirrhosis to hepatocellular carcinoma 77
Detection of platelet-activating factor in gingival tissue surrounding failed dental implants. 76
Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. 75
Alterazioni immunologiche in corso di uremia cronica. 73
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia. 72
Effect of leukocyte stimulation on rabbit immune complex glomerulonephritis. 72
Platelet-activating factor-induced endothelial cell expression of adhesion molecules and modulation of surface glycocalyx, evaluated by electron spectroscopy chemical analysis. 72
Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. 71
Determination of 1-O-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, platelet-activating factor and related phospholipids in biological samples by high-performance liquid chromatography--tandem mass spectrometry. J Chromatogr B Biomed Appl. 71
Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist. 71
The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition. 70
Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. 68
The role of platelet-activating factor in experimental immune complex pathology 66
Thrombopoietin (TPO) Contributes to Platelet Activation in Human Diseases 66
THROMBOPOIETIN MAY CONTRIBUTE TO VENTILATOR-INDUCED LUNG INJURY 65
Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. 65
Release of platelet-activating factor in systemic lupus erythematosus. 64
In vitro contractile effect of platelet-activating factor on guinea-pig myometrium. 64
Effect of platelet-activating factor (PAF) on human cardiac muscle. 61
Detection of platelet-activating factor in plasma of patients with streptococcal nephritis. 61
Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. 61
Platelet-activating factor-mediated contraction of rabbit lung strips: pharmacologic modulation. 60
The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophils. 60
Septic shock--the unravelling of molecular mechanisms. 59
Platelet-activating factor (PAF) induces platelet/neutrophil co-operation during myocardial reperfusion. 58
Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. 58
IN VITRO OXYTOCIC ACTIVITY OF PLATELET-ACTIVATING FACTOR OH HUMAN MYOMETRIUM 57
Prostacyclin inhibits the platelet-dependent effects of platelet-activating factor in the rabbit isolated heart. 57
Thrombopoietin contributes to enhanced platelet activation in patients with type 1 diabetes mellitus 57
Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells. 56
Role of platelet-activating factor in cardiovascular pathophysiology. 55
Involvement of thrombopoietin in the development of organ injury in a mouse model of cecal ligation and puncture-induced sepsis 55
Derivation and validation of a biomarker-based clinical algorithm to rule out sepsis from noninfectious systemic inflammatory response syndrome at emergency department admission: A multicenter prospective study 55
Isolated radiation-induced mitral stenosis: a yet undescribed valvulopathy 53
Platelet-activating factor and angiogenesis. 52
Release of Platelet activating factor (PAF) from ischemic reperfused rabbit heart 51
In vitro spasmogenic effect of platelet-activating factor on rabbit lung tissue. 50
Immunopathology and progression of experimental renal disease. 50
Thrombopoietin contributes to enhanced platelet activation in patients with unstable angina 50
Effects of heparin and its desulfated derivates on leukocyte-endothelial adhesion 48
Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome 48
Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. 46
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 46
Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes. 46
Role of platelet-activating factor in acute pancreatitis induced by lipopolysaccharides in rabbits. 45
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 45
Platelet-activating factor contracts human myometrium in vitro. 44
Platelet-activating factor biosynthesis by cultured mesangial cells is modulated by proteinase inhibitors. 42
Protective effect of Verapamil on the cardiac and circulatory alterations induced by Platelet activating factor 42
Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart. 42
Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle. 41
Potential angiogenic role of platelet-activating factor in human breast cancer. 41
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 41
Intra-plaque production of platelet-activating factor correlates with neoangiogenesis in human carotid atherosclerotic lesions 40
Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. 40
Regulation of polymorphonuclear cell activation by thrombopoietin. 40
Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases 39
Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart 39
Role of platelet-activating factor in hypotension andplatelet activation induced by infusion of thrombolytic agents in rabbits. 38
Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction. 37
La sepsi e lo shock settico. 37
Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. 36
Effects of recombinant human megakaryocyte growth and development factor on platelet activation. 36
Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor andP-selectin. 35
Platelet activating factor is produced during infectious peritonitis in CAPD patients 35
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 35
In vitro oxytocic activity of platelet-activating factor on human myometrium. 34
Role of soluble mediators in sepsis and renal failure. 33
Experimental acute pancreatitis induced by platelet activating factor in rabbits. 33
Totale 8.412
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.549
article - articoli 0
book - libri 0
conference - conferenze 431
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019466 0 0 0 18 40 72 20 84 26 48 121 37
2019/20201.562 25 35 97 59 131 261 223 122 140 149 182 138
2020/20211.062 96 56 72 38 75 53 130 53 140 127 67 155
2021/20221.461 98 78 77 133 66 93 176 105 72 101 202 260
2022/20231.712 214 119 43 139 137 438 148 108 218 25 86 37
2023/2024269 110 108 50 1 0 0 0 0 0 0 0 0
Totale 8.850